Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors (PEG)

This study has been completed.
Information provided by (Responsible Party):
Halozyme Therapeutics Identifier:
First received: January 29, 2009
Last updated: March 24, 2013
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)